Search…

New stock news | Shanghai Sheng Sheng Port IPO prospectus invalid

13/07/2026

According to the Finance and Economics App, the Hong Kong stock prospectus submitted by Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. (referred to as Shanghai Shengsheng) on January 13, 2026, expired after 6 months on July 13, 2026. China Jin and Guojin Securities (Hong Kong) acted as its joint sponsors.

Latest

2 m ago

Tianchen Bio-B (01779.HK): LP-003 clinical trial application for peanut allergy adaptation syndrome approved by FDA

2 m ago

Goldman Sachs stated that, following the results of the Johor state elections, the market is focusing on the relationship between the current government and its coalition parties, and the Malaysian Ringgit may experience volatility in the short term.

3 m ago

Stedik: The company's production and sales of MLCC separation films are running smoothly, and the proportion of high-end products is steadily increasing.

4 m ago

Xinlaiyingcai: By 2025, the revenue of the semiconductor industry will reach 956 million yuan, and the production base in Huai'an is progressing according to plan to release production capacity.

4 m ago

CITIC Securities: It is expected that the US stock market will continue to maintain a volatile upward trend.

See all latest